MAQUET HLS Cannulae with BIOLINE Coating - HSA Registration DE0013436
Access comprehensive regulatory information for MAQUET HLS Cannulae with BIOLINE Coating in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0013436 and owned by Maquet Cardiopulmonary GmbH. The device was registered on July 24, 2013.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The HLS Cannula is indicated for cannulation of all suitable vessels (e.g., femoral vessels) and forms the connection with the extracorporeal circulation. The cannula can be placed either by exposing the vessel or by means of the percutaneous Seldinger technique. Access for venous drainage is frequently via the femoral vein, jugular vein or subclavian vein (veno-arterial or veno-venous placement), and for arterial drainage, via the femoral artery (arterio-venous placement). Access for the arterial cannula is frequently via the femoral artery, subclavian artery or carotid artery (veno-arterial placement), or via the jugular vein, subclavian vein or femoral vein on the opposite side (veno-venous placement) and the femoral vein (arterio-venous placement). The decision on the application and the choice of venous and arterial access site is at the discretion of the surgeon and must be based on the anatomical conditions and the type of treatment planned. The maximum duration of use for the HLS Cannulae is 6 hours. The duration of use for the HLS Cannulae with BIOLINE COATING in combination with a PLS Set, ELS Set or HLS Set from MAQUET is up to 30 days.